Search
Illumina Inc
ILMNAdd to Watchlist
161.360USD
-0.570-0.35%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
24.53BMarket Cap
29.15P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Illumina Inc is 7.27, ranking 148 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 120.00, with a high of 195.00 and a low of 80.00.
Analyst Rating
Based on
21
analysts
Buy
Current Rating
145.681
Target Price
-10.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Illumina Inc
ILMN
21
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Illumina Inc's expected revenue for the next quarter?
Illumina Inc's expected revenue is 1.13B.
What is Illumina Inc's price target?
Analysts forecast that Illumina Inc's price target is USD 120.00, with the highest forecast at USD 195.00 and the lowest forecast at USD 80.00.
How have Illumina IncILMN's recent earnings per share performed?
The market expectation was USD 0.88, while Illumina IncILMN's earnings per share (EPS) for the previous quarter was USD 2.20. EPS for the next quarter is expected at USD 1.23.
What is the analyst rating for Illumina Inc?
Based on the ratings of Illumina Inc's stock from 21 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
